Multi-Omics Research in Autism
GEMMA is a consortium of international researchers who have been awarded €14.2M of research funding from the EU. GEMMA will conduct ground-breaking research that will, for the first time, follow children who are at risk of developing autism infants of age 0-6 months siblings of ASD children from 0-6 months of age.
This research may lead to earlier diagnosis than is currently possible and help researcher to understand why some children develop autism and others do not.
Who can join?
GEMMA will follow 600 infants in Ireland, Italy and the US at risk of developing autism infants of age 0-6 months siblings of ASD children. We are particularly interested in hearing from families if:
They have a child with autism and have another child 0-6 months or are waiting for or planning a baby
If you choose to participate in the project, GEMMA will monitor your child’s development and will administer an autism assessment every six months. If your child develops the condition, you will receive a diagnosis as early as possible which will allow you to access early intervention. If your child doesn’t develop autism, you will have access to this information at the earliest possible age.
How to partecipate
If you would like to get involved in GEMMA or you would like more information, please contact the center closest to you:
Three patient recruitment centers are involved to allow a global sampling based on their geographical coverage:
- National University Of Ireland Galway (NUIG) www.nuigalway.ie
- Irish Centre for Autism and Neurodevelopment Research (ICAN), Ireland firstname.lastname@example.org
- ASL Salerno, Italy: www.aslsalerno.it/ , email@example.com
- The General Hospital Corporation, MGH, Boston, U.S.A., www.partners.org, firstname.lastname@example.org